Experts Guide for Media

Topic: Health care economics

Kyle Grazier Kyle Grazier, PhD

Professor of Health Management and Policy
Phone: 734-936-1222 E-mail: kgrazier@umich.edu
Faculty Profile

  • Focuses on health care finance--including insurance, benefit design, actuarial science, managed care, and risk adjustment methods on mental health and substance abuse services.
  • With expertise in health care plans (benefit design, service integration, pricing premiums), she chaired 2003 University of Michigan Committee on Health Insurance Premium Design.
  • Studies cost and quality of mental health service, behavioral health carve-outs, integrating mental health and primary care.
  • Studies long-term impacts of alcoholism in community populations.

Other topics for Kyle Grazier

SPH Faculty Experts for Health care economics

Daniel EisenbergDaniel Eisenberg, Ph.D.

Assistant Professor in Health Management and Policy
Phone: (734) 615-7764 E-mail: daneis@umich.edu

  • Dr. Eisenberg's research interests relate to mental health services and policy, mainly with young and college-age people (a time that many mental disorders start).     MORE

A. Mark FendrickA. Mark Fendrick, MD

Professor in Health Management and Policy
Phone: (734) 647-9688 E-mail: amfen@umich.edu

  • Practicing internist and professor of internal medicine at UM whose interest focuses on the clinical and economic impact of innovative medical interventions.     MORE

Kyle GrazierKyle Grazier, PhD

Professor in Health Management and Policy
Phone: 734-936-1222 E-mail: kgrazier@umich.edu

  • Focuses on health care finance--including insurance, benefit design, actuarial science, managed care, and risk adjustment methods on mental health and substance abuse services.     MORE

Richard HirthRichard Hirth, Ph.D.

Professor and Chair in Health Management and Policy
Phone: 734-936-1306 E-mail: rhirth@umich.edu

  • Research interests include the role of not-for-profit providers in health care markets, health insurance, the relationship between managed care and the adoption and utilization of medical technologies, long-term care, and the economics of end-stage renal disease care.     MORE

Browse/Search